Search Results 371-380 of 16763 for alt

1. PORtopulmonary Hypertension Treatment WIth MaCitentan ─ A RandOmized Clinical Trial - Mayo Clinic

   ALT/AST >= 3 x ULN; Bilirubin >= 3 mg/dL at Screening; Any known factor or disease that might interfere with treatment compliance, study conduct, or ...

2. A Study of ONO-7475 in Patients With Acute Leukemias - Mayo Clinic

   AST and ALT ≤ 2.5 x ULN;; Calculated creatinine clearance ≥ 45 mL/min.;; Serum albumin ≥ 2.5 g/dL. For any patient with laboratory values outside the ...

3. Humans With Obesity Response to Exercise - Mayo Clinic

   ... (ALT) \>165 IU/L) * Oral warfarin group medications or history of blood clotting disorders. * Smoking * Pregnancy or breastfeeding * Alcohol consumption ...

4. A Study to Evaluate Fostamatinib Disodium to Treat Warm Antibody Autoimmune Hemolytic Anemia - Mayo Clinic

   ... [ALT] or aspartate aminotransferase [AST]) > 1.5 x ULN. Has documented active hepatitis B or hepatitis C infection or HIV infection. Participating Mayo ...

5. A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03) - Mayo Clinic

   ... ALT < 3 × ULN that are not attributable to HBV infection), and are willing to start and maintain antiviral treatment for the duration of the study, are allowed.

6. A Study To Assess The Effectiveness, Safety And Tolerability Of Dupilumab In Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) With Type 2 Inflammation - Mayo Clinic

   Alanine transaminase (ALT) > 3 times upper limit of normal range (ULN);; Hemoglobin < 10g /100 mL for male and < 9g/ 100 mL for female;; Platelets < 100 000 ...

7. Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis - Mayo Clinic

   ALT >3 times upper limit of normal (ULN) or AST >5 times ULN during screening. Initiation or discontinuation of non-selective beta blockers within 1 month ...

8. A Trial of TTI-621 for Patients With Hematologic Malignancies and Selected Solid Tumors - Mayo Clinic

   alanine aminotransferase (ALT) and aspartate aminotransferase (AST) < 1.5 x ULN or < 3 x ULN with documented liver metastases. Adequate renal function ...

9. Veliparib with or without Carboplatin in Treating Patients with Stage III or Stage IV Breast Cancer - Mayo Clinic

   Aspartate aminotransferase (AST) serum glutamic oxaloacetic transaminase (SGOT) and alanine aminotransferase (ALT) serum glutamate pyruvate transaminase ...

10. IL-2 plus FOLFOX and Nivolumab for Treatment of Peritoneal Metastases - Mayo Clinic

    Alanine aminotransferase (ALT) AND aspartate transaminase (AST) ≤ 1.5 x ULN;; PT/INR/aPTT ≤ 1.5 x ULN; OR if patient is receiving anticoagulant therapy ...